Clarification sought from Neuland Laboratories

01 Mar 2017 Evaluate

The Exchange has sought clarification from Neuland Laboratories on March 01, 2017 with reference to news flashed on ET Now dated March 01, 2017, ‘US FDA grants priority review for SD-809’.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

13611.80 443.95 (3.37%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×